vs

Side-by-side financial comparison of Innoviz Technologies Ltd. (INVZ) and PRO DEX INC (PDEX). Click either name above to swap in a different company.

PRO DEX INC is the larger business by last-quarter revenue ($18.7M vs $15.3M, roughly 1.2× Innoviz Technologies Ltd.). PRO DEX INC runs the higher net margin — 11.7% vs -100.9%, a 112.6% gap on every dollar of revenue. PRO DEX INC produced more free cash flow last quarter ($3.5M vs $-14.0M).

Luminar Technologies Inc. was an American technology company that developed vision-based lidar and machine perception technologies, primarily for self-driving cars. The company's headquarters and main research and development facilities were in Orlando, Florida; a second major office was located in Palo Alto, California.

Pro Dex Inc is a precision manufacturing enterprise that produces custom machined components, subassemblies and finished products primarily for medical device original equipment manufacturers, as well as clients in the aerospace and industrial sectors, with its core operating market covering North America.

INVZ vs PDEX — Head-to-Head

Bigger by revenue
PDEX
PDEX
1.2× larger
PDEX
$18.7M
$15.3M
INVZ
Higher net margin
PDEX
PDEX
112.6% more per $
PDEX
11.7%
-100.9%
INVZ
More free cash flow
PDEX
PDEX
$17.5M more FCF
PDEX
$3.5M
$-14.0M
INVZ

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
INVZ
INVZ
PDEX
PDEX
Revenue
$15.3M
$18.7M
Net Profit
$-15.4M
$2.2M
Gross Margin
15.0%
30.8%
Operating Margin
-103.4%
17.5%
Net Margin
-100.9%
11.7%
Revenue YoY
11.1%
Net Profit YoY
7.2%
EPS (diluted)
$-0.08
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INVZ
INVZ
PDEX
PDEX
Q4 25
$18.7M
Q3 25
$15.3M
$18.5M
Q2 25
$17.5M
Q1 25
$17.4M
Q4 24
$16.8M
Q3 24
$14.9M
Q2 24
$15.0M
Q1 24
$14.3M
Net Profit
INVZ
INVZ
PDEX
PDEX
Q4 25
$2.2M
Q3 25
$-15.4M
$4.7M
Q2 25
$1.2M
Q1 25
$3.3M
Q4 24
$2.0M
Q3 24
$2.5M
Q2 24
$1.6M
Q1 24
$655.0K
Gross Margin
INVZ
INVZ
PDEX
PDEX
Q4 25
30.8%
Q3 25
15.0%
29.0%
Q2 25
19.9%
Q1 25
33.3%
Q4 24
30.2%
Q3 24
34.6%
Q2 24
27.2%
Q1 24
28.0%
Operating Margin
INVZ
INVZ
PDEX
PDEX
Q4 25
17.5%
Q3 25
-103.4%
16.8%
Q2 25
7.7%
Q1 25
20.9%
Q4 24
16.0%
Q3 24
20.2%
Q2 24
15.6%
Q1 24
15.5%
Net Margin
INVZ
INVZ
PDEX
PDEX
Q4 25
11.7%
Q3 25
-100.9%
25.3%
Q2 25
6.8%
Q1 25
18.8%
Q4 24
12.1%
Q3 24
16.6%
Q2 24
10.6%
Q1 24
4.6%
EPS (diluted)
INVZ
INVZ
PDEX
PDEX
Q4 25
$0.66
Q3 25
$-0.08
$1.40
Q2 25
$0.33
Q1 25
$0.98
Q4 24
$0.61
Q3 24
$0.75
Q2 24
$0.44
Q1 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INVZ
INVZ
PDEX
PDEX
Cash + ST InvestmentsLiquidity on hand
$17.3M
$6.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$89.7M
$41.6M
Total Assets
$151.1M
$62.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INVZ
INVZ
PDEX
PDEX
Q4 25
$6.1M
Q3 25
$17.3M
$10.1M
Q2 25
$6.8M
Q1 25
$5.5M
Q4 24
$4.7M
Q3 24
$7.8M
Q2 24
$6.8M
Q1 24
$7.8M
Total Debt
INVZ
INVZ
PDEX
PDEX
Q4 25
Q3 25
Q2 25
$15.4M
Q1 25
Q4 24
Q3 24
Q2 24
$12.0M
Q1 24
Stockholders' Equity
INVZ
INVZ
PDEX
PDEX
Q4 25
$41.6M
Q3 25
$89.7M
$41.5M
Q2 25
$36.6M
Q1 25
$35.3M
Q4 24
$31.8M
Q3 24
$30.9M
Q2 24
$30.9M
Q1 24
$30.9M
Total Assets
INVZ
INVZ
PDEX
PDEX
Q4 25
$62.3M
Q3 25
$151.1M
$64.3M
Q2 25
$61.2M
Q1 25
$64.3M
Q4 24
$60.4M
Q3 24
$54.3M
Q2 24
$52.5M
Q1 24
$50.5M
Debt / Equity
INVZ
INVZ
PDEX
PDEX
Q4 25
Q3 25
Q2 25
0.42×
Q1 25
Q4 24
Q3 24
Q2 24
0.39×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INVZ
INVZ
PDEX
PDEX
Operating Cash FlowLast quarter
$-13.7M
$3.6M
Free Cash FlowOCF − Capex
$-14.0M
$3.5M
FCF MarginFCF / Revenue
-91.7%
18.8%
Capex IntensityCapex / Revenue
1.9%
0.4%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INVZ
INVZ
PDEX
PDEX
Q4 25
$3.6M
Q3 25
$-13.7M
$2.3M
Q2 25
$-173.0K
Q1 25
$754.0K
Q4 24
$-4.2M
Q3 24
$1.9M
Q2 24
$1.0M
Q1 24
$4.1M
Free Cash Flow
INVZ
INVZ
PDEX
PDEX
Q4 25
$3.5M
Q3 25
$-14.0M
$2.2M
Q2 25
Q1 25
$574.0K
Q4 24
$-4.7M
Q3 24
$1.5M
Q2 24
Q1 24
$4.0M
FCF Margin
INVZ
INVZ
PDEX
PDEX
Q4 25
18.8%
Q3 25
-91.7%
11.9%
Q2 25
Q1 25
3.3%
Q4 24
-27.9%
Q3 24
9.8%
Q2 24
Q1 24
27.7%
Capex Intensity
INVZ
INVZ
PDEX
PDEX
Q4 25
0.4%
Q3 25
1.9%
0.5%
Q2 25
Q1 25
1.0%
Q4 24
3.2%
Q3 24
2.9%
Q2 24
Q1 24
0.8%
Cash Conversion
INVZ
INVZ
PDEX
PDEX
Q4 25
1.63×
Q3 25
0.49×
Q2 25
-0.14×
Q1 25
0.23×
Q4 24
-2.03×
Q3 24
0.77×
Q2 24
0.66×
Q1 24
6.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons